Aptose Biosciences Inc. Liquidation Value
APTOF
Other
Cash & Equivalents
$935,000
As of 2025-12-31
Current Price: $1.71 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $935,000
Total Obligations: -$9.50M
$-8.56M
Per share: $-3.36
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $935,000
AR: $0
Total Obligations: -$9.50M
$-8.56M
Per share: $-3.36
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $935,000
AR: $0
Inventory: $0
Total Obligations: -$9.50M
$-8.56M
Per share: $-3.36
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-8.56M | $-3.36 |
| Liquid Liquidation Value | $-8.56M | $-3.36 |
| Operating Liquidation Value | $-8.56M | $-3.36 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $935,000 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $9.31M |
| Long-term Debt | N/A |
| Op. Lease Liability | $193,000 |
| Finance Lease | N/A |
| Shares Outstanding | 2.6M |
Explore all 118 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $935,000 | N/A | N/A | $2.91M | $9.31M | N/A | $193,000 | N/A |
| 2025-09-30 | $613,000 | N/A | N/A | $1.46M | $7.08M | N/A | $305,000 | N/A |
| 2025-06-30 | $553,000 | N/A | N/A | $2.88M | $9.00M | N/A | $413,000 | N/A |
| 2025-03-31 | $4.74M | N/A | N/A | $2.39M | $6.32M | N/A | $521,000 | N/A |
| 2024-12-31 | $6.15M | N/A | N/A | $1.26M | $4.46M | N/A | $621,000 | N/A |
| 2024-09-30 | $7.96M | N/A | N/A | $1.83M | $9.76M | N/A | $721,000 | N/A |
| 2024-06-30 | $8.33M | N/A | N/A | $7.11M | $12.71M | N/A | $818,000 | N/A |
| 2024-03-31 | $7.35M | N/A | N/A | $2.42M | $12.14M | N/A | $919,000 | N/A |
▼ Community Notes